Indore Lab Under Scrutiny: Suspected of Issuing Manipulated Drug Reports Without Proper Testing,pious labs
February – In a shocking revelation, the Pious Lab located in the Rangwasa area of Indore has come under intense scrutiny following a surprise raid by the Food and Drug…
Drug Inspector, Aide Caught By ACB Taking ₹20,000 Bribe
KAKINADA: Anti-Corruption Bureau (ACB) officials on Friday caught Drug Inspector Kampa Suresh Kumar of Jangareddygudem and his alleged private aide, Tadikamalla Siva Ramakrishna, red-handed while accepting a bribe of ₹20,000.…
Controlled substances charge: Court summons Ramdev, Amazon founder
Hisar: The court of chief judicial magistrate Gitanjaali Goel in Ambala has issued summons to 14 people, including yoga guru Baba Ramdev, Acharya Balkrishna, and Amazon founder and executive chairman…
IPC registers 44 small-scale medtech firms under ADRMS
Mumbai: The Indian Pharmacopoeia Commission (IPC) has registered 44 small-scale medtech firms under ADR Monitoring System (ADRMS) to help them report medical devices related serious adverse events (SAEs) for patient and…
Draft issued to remove cough syrups from Schedule K
New Delhi: The Union health ministry has proposed an amendment to remove cough syrups from Schedule K, to make its sales strictly under prescription of a medical practitioner. The move…
Telangana Rising Vision Document Aims for USD 3 Trillion Economy
Hyderabad: Telangana Chief Minister A Revanth Reddy has introduced the Telangana Rising vision document, which aims to transform the state into a USD three trillion economy by 2047. This announcement…
Ujjain Set to Become Medical Device Manufacturing Hub: 11 Major Firms Pledge ₹600 Crore Investment, 1,700+ Jobs
Ujjain, Madhya Pradesh– In a significant boost to Madhya Pradesh’s industrial landscape, 11 leading companies from the health sector have committed to investing a staggering ₹600 crore in Ujjain’s Vikram…
PCI directs State Councils to strictly comply with norms related to appointment of registrars
New Delhi: The Pharmacy Council of India (PCI) has asked the State Pharmacy Councils to strictly comply with the regulations related to the qualifications while appointing registrar in their respective…
Novartis Phase III trial for malaria treatment KLU156 (GanLum) meets primary endpoint, with potential to combat antimalarial resistance
Basel– Novartis today announced positive results from KALUMA, a Phase III study for new malaria treatment KLU156 (ganaplacide/ lumefantrine, or GanLum). The novel non-artemisinin antimalarial, which was developed with Medicines…
Rampant Quackery in Rural India: Unqualified ‘Doctors’ Amass Fortunes Amid Lax Enforcement
New Delhi– In the vast expanses of rural India, where government healthcare infrastructure falls short, millions rely on unqualified practitioners—commonly known as quacks—for primary medical care. These individuals, often lacking…
%20meets%20primary%20endpoint,%20with%20potential%20to%20combat%20antimalarial%20resistance){kind=link}
